Study design, baseline patient characteristics and intervention in a cross-cultural framework

Results from the ADORE study

Ulrich Preuss, Stephen J. Ralston, Gisli Baldursson, Bruno Falissard, Maria J. Lorenzo, Rob Rodrigues Pereira, Laurens Vlasveld, David Coghill, P. Curatolo, S. Dalsgaard, M. Döpfner, A. Hervas, M. F. Le Heuzey, T. S. Nøvik, P. Rasmussen, Anne W Riley, A. Rothenberger, G. Spiel, H. C. Steinhausen

Research output: Contribution to journalArticle

Abstract

Objective: To describe the methodology and to present the baseline findings of the Attention-deficit/hyperactivity Disorder Observational Research in Europe (ADORE) study, the primary objective of which is to describe the relationship between treatment regimen prescribed and quality of life of children with ADHD in actual practice. Methods: In this 2-year prospective observational study, data on diagnosis, prescribed treatment and outcomes of ADHD were collected at seven time points by paediatricians and child psychiatrists on 1,573 children recruited in 10 European countries. The data presented here from the 1,478 patients included in the analyses describe the baseline condition, initial treatment regimen prescribed and quality of life of families with children with ADHD. Results: Patients had a mean age of 9.0 years (SD 2.5) and 84% were male. Physicians diagnoses were made using DSM-IV (43 %), ICD-10 (32%) and both DSM-IV and ICD-10 (12 %). Mean age of awareness of a problem was 5.1 years, suggesting an average delay of approximately 4 years between awareness and diagnosis of ADHD. Baseline ADHD rating scale scores (physicianrated) indicated moderate to severe ADHD. Parent-rated SDQ scores were in agreement and suggested significant levels of co-existing problems. CGI-S, CGAS and CHIPCE scores also indicated significant impairment. Patients were offered the following treatments after the initial assessment: pharmacotherapy (25 %), psychotherapy (19 %), combination of pharmacotherapy and psychotherapy (25 %), other therapy (10 %) and no treatment (21 %). Conclusion: The ADORE study shows that ADHD is similarly recognised across 10 European countries and that the children are significantly impaired across a wide range of domains. In this respect, they resemble children described in previous ADHD samples.

Original languageEnglish (US)
JournalEuropean Child and Adolescent Psychiatry
Volume15
Issue numberSUPPL. 1
DOIs
StatePublished - Dec 2006
Externally publishedYes

Fingerprint

Attention Deficit Disorder with Hyperactivity
Research
International Classification of Diseases
Psychotherapy
Diagnostic and Statistical Manual of Mental Disorders
Quality of Life
Therapeutics
Drug Therapy
Observational Studies
Psychiatry
Prospective Studies
Physicians

Keywords

  • ADHD
  • Children
  • Europe
  • Quality of life
  • Symptoms

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Developmental and Educational Psychology

Cite this

Preuss, U., Ralston, S. J., Baldursson, G., Falissard, B., Lorenzo, M. J., Rodrigues Pereira, R., ... Steinhausen, H. C. (2006). Study design, baseline patient characteristics and intervention in a cross-cultural framework: Results from the ADORE study. European Child and Adolescent Psychiatry, 15(SUPPL. 1). https://doi.org/10.1007/s00787-006-1002-0

Study design, baseline patient characteristics and intervention in a cross-cultural framework : Results from the ADORE study. / Preuss, Ulrich; Ralston, Stephen J.; Baldursson, Gisli; Falissard, Bruno; Lorenzo, Maria J.; Rodrigues Pereira, Rob; Vlasveld, Laurens; Coghill, David; Curatolo, P.; Dalsgaard, S.; Döpfner, M.; Hervas, A.; Le Heuzey, M. F.; Nøvik, T. S.; Rasmussen, P.; Riley, Anne W; Rothenberger, A.; Spiel, G.; Steinhausen, H. C.

In: European Child and Adolescent Psychiatry, Vol. 15, No. SUPPL. 1, 12.2006.

Research output: Contribution to journalArticle

Preuss, U, Ralston, SJ, Baldursson, G, Falissard, B, Lorenzo, MJ, Rodrigues Pereira, R, Vlasveld, L, Coghill, D, Curatolo, P, Dalsgaard, S, Döpfner, M, Hervas, A, Le Heuzey, MF, Nøvik, TS, Rasmussen, P, Riley, AW, Rothenberger, A, Spiel, G & Steinhausen, HC 2006, 'Study design, baseline patient characteristics and intervention in a cross-cultural framework: Results from the ADORE study', European Child and Adolescent Psychiatry, vol. 15, no. SUPPL. 1. https://doi.org/10.1007/s00787-006-1002-0
Preuss, Ulrich ; Ralston, Stephen J. ; Baldursson, Gisli ; Falissard, Bruno ; Lorenzo, Maria J. ; Rodrigues Pereira, Rob ; Vlasveld, Laurens ; Coghill, David ; Curatolo, P. ; Dalsgaard, S. ; Döpfner, M. ; Hervas, A. ; Le Heuzey, M. F. ; Nøvik, T. S. ; Rasmussen, P. ; Riley, Anne W ; Rothenberger, A. ; Spiel, G. ; Steinhausen, H. C. / Study design, baseline patient characteristics and intervention in a cross-cultural framework : Results from the ADORE study. In: European Child and Adolescent Psychiatry. 2006 ; Vol. 15, No. SUPPL. 1.
@article{05f0eebcb40a4ab38818c5bb4511862b,
title = "Study design, baseline patient characteristics and intervention in a cross-cultural framework: Results from the ADORE study",
abstract = "Objective: To describe the methodology and to present the baseline findings of the Attention-deficit/hyperactivity Disorder Observational Research in Europe (ADORE) study, the primary objective of which is to describe the relationship between treatment regimen prescribed and quality of life of children with ADHD in actual practice. Methods: In this 2-year prospective observational study, data on diagnosis, prescribed treatment and outcomes of ADHD were collected at seven time points by paediatricians and child psychiatrists on 1,573 children recruited in 10 European countries. The data presented here from the 1,478 patients included in the analyses describe the baseline condition, initial treatment regimen prescribed and quality of life of families with children with ADHD. Results: Patients had a mean age of 9.0 years (SD 2.5) and 84{\%} were male. Physicians diagnoses were made using DSM-IV (43 {\%}), ICD-10 (32{\%}) and both DSM-IV and ICD-10 (12 {\%}). Mean age of awareness of a problem was 5.1 years, suggesting an average delay of approximately 4 years between awareness and diagnosis of ADHD. Baseline ADHD rating scale scores (physicianrated) indicated moderate to severe ADHD. Parent-rated SDQ scores were in agreement and suggested significant levels of co-existing problems. CGI-S, CGAS and CHIPCE scores also indicated significant impairment. Patients were offered the following treatments after the initial assessment: pharmacotherapy (25 {\%}), psychotherapy (19 {\%}), combination of pharmacotherapy and psychotherapy (25 {\%}), other therapy (10 {\%}) and no treatment (21 {\%}). Conclusion: The ADORE study shows that ADHD is similarly recognised across 10 European countries and that the children are significantly impaired across a wide range of domains. In this respect, they resemble children described in previous ADHD samples.",
keywords = "ADHD, Children, Europe, Quality of life, Symptoms",
author = "Ulrich Preuss and Ralston, {Stephen J.} and Gisli Baldursson and Bruno Falissard and Lorenzo, {Maria J.} and {Rodrigues Pereira}, Rob and Laurens Vlasveld and David Coghill and P. Curatolo and S. Dalsgaard and M. D{\"o}pfner and A. Hervas and {Le Heuzey}, {M. F.} and N{\o}vik, {T. S.} and P. Rasmussen and Riley, {Anne W} and A. Rothenberger and G. Spiel and Steinhausen, {H. C.}",
year = "2006",
month = "12",
doi = "10.1007/s00787-006-1002-0",
language = "English (US)",
volume = "15",
journal = "European Child and Adolescent Psychiatry",
issn = "1018-8827",
publisher = "D. Steinkopff-Verlag",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Study design, baseline patient characteristics and intervention in a cross-cultural framework

T2 - Results from the ADORE study

AU - Preuss, Ulrich

AU - Ralston, Stephen J.

AU - Baldursson, Gisli

AU - Falissard, Bruno

AU - Lorenzo, Maria J.

AU - Rodrigues Pereira, Rob

AU - Vlasveld, Laurens

AU - Coghill, David

AU - Curatolo, P.

AU - Dalsgaard, S.

AU - Döpfner, M.

AU - Hervas, A.

AU - Le Heuzey, M. F.

AU - Nøvik, T. S.

AU - Rasmussen, P.

AU - Riley, Anne W

AU - Rothenberger, A.

AU - Spiel, G.

AU - Steinhausen, H. C.

PY - 2006/12

Y1 - 2006/12

N2 - Objective: To describe the methodology and to present the baseline findings of the Attention-deficit/hyperactivity Disorder Observational Research in Europe (ADORE) study, the primary objective of which is to describe the relationship between treatment regimen prescribed and quality of life of children with ADHD in actual practice. Methods: In this 2-year prospective observational study, data on diagnosis, prescribed treatment and outcomes of ADHD were collected at seven time points by paediatricians and child psychiatrists on 1,573 children recruited in 10 European countries. The data presented here from the 1,478 patients included in the analyses describe the baseline condition, initial treatment regimen prescribed and quality of life of families with children with ADHD. Results: Patients had a mean age of 9.0 years (SD 2.5) and 84% were male. Physicians diagnoses were made using DSM-IV (43 %), ICD-10 (32%) and both DSM-IV and ICD-10 (12 %). Mean age of awareness of a problem was 5.1 years, suggesting an average delay of approximately 4 years between awareness and diagnosis of ADHD. Baseline ADHD rating scale scores (physicianrated) indicated moderate to severe ADHD. Parent-rated SDQ scores were in agreement and suggested significant levels of co-existing problems. CGI-S, CGAS and CHIPCE scores also indicated significant impairment. Patients were offered the following treatments after the initial assessment: pharmacotherapy (25 %), psychotherapy (19 %), combination of pharmacotherapy and psychotherapy (25 %), other therapy (10 %) and no treatment (21 %). Conclusion: The ADORE study shows that ADHD is similarly recognised across 10 European countries and that the children are significantly impaired across a wide range of domains. In this respect, they resemble children described in previous ADHD samples.

AB - Objective: To describe the methodology and to present the baseline findings of the Attention-deficit/hyperactivity Disorder Observational Research in Europe (ADORE) study, the primary objective of which is to describe the relationship between treatment regimen prescribed and quality of life of children with ADHD in actual practice. Methods: In this 2-year prospective observational study, data on diagnosis, prescribed treatment and outcomes of ADHD were collected at seven time points by paediatricians and child psychiatrists on 1,573 children recruited in 10 European countries. The data presented here from the 1,478 patients included in the analyses describe the baseline condition, initial treatment regimen prescribed and quality of life of families with children with ADHD. Results: Patients had a mean age of 9.0 years (SD 2.5) and 84% were male. Physicians diagnoses were made using DSM-IV (43 %), ICD-10 (32%) and both DSM-IV and ICD-10 (12 %). Mean age of awareness of a problem was 5.1 years, suggesting an average delay of approximately 4 years between awareness and diagnosis of ADHD. Baseline ADHD rating scale scores (physicianrated) indicated moderate to severe ADHD. Parent-rated SDQ scores were in agreement and suggested significant levels of co-existing problems. CGI-S, CGAS and CHIPCE scores also indicated significant impairment. Patients were offered the following treatments after the initial assessment: pharmacotherapy (25 %), psychotherapy (19 %), combination of pharmacotherapy and psychotherapy (25 %), other therapy (10 %) and no treatment (21 %). Conclusion: The ADORE study shows that ADHD is similarly recognised across 10 European countries and that the children are significantly impaired across a wide range of domains. In this respect, they resemble children described in previous ADHD samples.

KW - ADHD

KW - Children

KW - Europe

KW - Quality of life

KW - Symptoms

UR - http://www.scopus.com/inward/record.url?scp=33845794758&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845794758&partnerID=8YFLogxK

U2 - 10.1007/s00787-006-1002-0

DO - 10.1007/s00787-006-1002-0

M3 - Article

VL - 15

JO - European Child and Adolescent Psychiatry

JF - European Child and Adolescent Psychiatry

SN - 1018-8827

IS - SUPPL. 1

ER -